Form D · Other Health Care
OraPharma Topco Holdings, Inc.
Chicago, IL · CIK 0001509962
Offering snapshot reported Jan 12, 2011 · SEC filing
- Reported sold
- $88.5M Offering amount: $88.5M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 28, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 12, 2011 | Initial | $88,500,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-153519
Source: Form D, filed Jan 12, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alan L Heller | Director |
| Janet Vergis | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Water Street Healthcare Partners 333 W. Wacker Drive, Suite 2800
Chicago, IL, 60606
Chicago, IL, 60606